tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

AFC-HD AMS Life Science Co., Ltd. Reports Strong Financial Performance for FY 2025

Story Highlights
AFC-HD AMS Life Science Co., Ltd. Reports Strong Financial Performance for FY 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An announcement from AFC-HD AMS Life Science Co., Ltd. ( (JP:2927) ) is now available.

AFC-HD AMS Life Science Co., Ltd. reported an 8.2% increase in net sales and a 25.7% rise in operating profit for the fiscal year ending August 2025, indicating strong financial performance. The company’s improved profitability and financial position, with a notable increase in comprehensive income by 37.8%, suggest a positive outlook for stakeholders and enhanced industry positioning.

The most recent analyst rating on (JP:2927) stock is a Buy with a Yen970.00 price target. To see the full list of analyst forecasts on AFC-HD AMS Life Science Co., Ltd. stock, see the JP:2927 Stock Forecast page.

More about AFC-HD AMS Life Science Co., Ltd.

AFC-HD AMS Life Science Co., Ltd. is a company listed on the Tokyo Stock Exchange under the securities code 29270. It operates in the general business category and focuses on life sciences, offering products and services that cater to this industry.

Average Trading Volume: 41,408

Technical Sentiment Signal: Strong Buy

Current Market Cap: Yen12.11B

For detailed information about 2927 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1